Global research agenda for antimicrobial resistance in human health

  23 June 2023

The global research agenda for antimicrobial resistance in human health prioritizes 40 research topics for evidence generation to inform policy by 2030. It aims to guide policy-makers, researchers, funders, implementing partners, industry and civil society in generating new evidence to inform antimicrobial resistance policies and interventions as part of efforts to address antimicrobial resistance, especially in low-and-middle-income countries.

The research agenda is global in scope and focuses on antimicrobial resistance in the human health sector, especially infections caused by the WHO bacterial priority pathogens and WHO fungal priority pathogens with critical importance for antimicrobial resistance (such as Candida auris, Aspergillus fumigatus and Cryptococcus neoformans), and drug-resistant Mycobacterium tuberculosis.

Further reading: WHO
Author(s): WHO
Smart Innovations  
Back

OUR UNDERWRITERS

Unrestricted financial support by:

Antimicrobial Resistance Fighter Coalition

Bangalore Bioinnovation Centre

INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS

BD





AMR NEWS

Every two weeks in your inbox

Because there should be one newsletter that brings together all One Health news related to antimicrobial resistance: AMR NEWS!

Subscribe

What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!

Keep me informed